HOWARD WEINER to Administration, Intranasal
This is a "connection" page, showing publications HOWARD WEINER has written about Administration, Intranasal.
Connection Strength
0.732
-
Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer's Disease Dementia. Clin Nucl Med. 2025 Aug 01; 50(8):756-757.
Score: 0.222
-
Nasal anti-CD3 monoclonal antibody ameliorates traumatic brain injury, enhances microglial phagocytosis and reduces neuroinflammation via IL-10-dependent Treg-microglia crosstalk. Nat Neurosci. 2025 Mar; 28(3):499-516.
Score: 0.219
-
Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study. Front Immunol. 2021; 12:709861.
Score: 0.171
-
IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation. Brain. 2016 07; 139(Pt 7):1939-57.
Score: 0.119